|
|
Efficacy and safety of febuxostat in 73 gouty patients with stage 4/5 chronic kidney disease: A retrospective study of 10 centers
Pierre-Antoine Juge
,
Marie-Elise Truchetet
,
Evangeline Pillebout
,
Sébastien Ottaviani
,
Cécile Vigneau
et al.
Journal articles
hal-02445528v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
GOSPEL 4 - Patients with early onset gout develop earlier severe joint involvement and metabolic comorbid conditions
Tristan Pascart
,
Laurène Norberciak
,
Hang-Korng Ea
,
Pascal Guggenbuhl
,
Frédéric Lioté
et al.
Arthritis Care & Research = Arthritis Care and Research, 2019, 71 (7), pp.986-992. ⟨10.1002/acr.23706⟩
Journal articles
hal-01862578v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Difficult-to-treat gout flares eligibility for interleukin-1 inhibition in private practice is uncommon according to current EMA approval
Tristan Pascart
,
Laurène Norberciak
,
Hang-Korng Ea
,
Sahara Graf
,
Pascal Guggenbuhl
et al.
Journal articles
hal-02179667v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Risk of cutaneous adverse events with febuxostat treatment in patients with skin reaction to allopurinol. A retrospective, hospital-based study of 101 patients with consecutive allopurinol and febuxostat treatment
Thomas Bardin
,
Gérard Chales
,
Tristan Pascart
,
René-Marc Flipo
,
Hang Korng Ea
et al.
Journal articles
hal-01255828v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
GOSPEL 2 – la colchicine dans le traitement de la crise de goutte en France – analyse d’un sous-groupe de l’étude GOSPEL. Doses utilisées en pratique courante sans considération de l’insuffisance rénale et de l’âge
Tristan Pascart
,
Sylvie Lancrenon
,
Sabine Lanz
,
Catherine Delva
,
Pascal Guggenbuhl
et al.
Journal articles
hal-01630464v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficacy and Safety of Febuxostat in 55 Gouty Patients with Stage 4/5 Chronic Kidney Disease: Results from a Retrospective Multicenter Study
Pierre-Antoine Juge
,
Marie-Elise Truchetet
,
Sébastien Ottaviani
,
Cécile Vigneau
,
Clotilde Loustau
et al.
2015 ACR/ARHP Annual Meeting, 2015, San Francisco, United States. pp.2833-2834
Conference papers
hal-01300815v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
GOSPEL 2 – Colchicine for the treatment of gout flares in France – a GOSPEL survey subgroup analysis. Doses used in common practices regardless of renal impairment and age
Tristan Pascart
,
Sylvie Lancrenon
,
Sabine Lanz
,
Catherine Delva
,
Pascal Guggenbuhl
et al.
Journal articles
hal-01282350v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
2020 recommendations from the French Society of Rheumatology for the management of gout: Urate-lowering therapy
Tristan Pascart
,
Augustin Latourte
,
René-Marc Flipo
,
Gérard Chalès
,
Laurence Coblentz-Baumann
et al.
Journal articles
hal-03492350v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
2020 Recommendations from the French Society of Rheumatology for the management of gout: Management of acute flares
Augustin Latourte
,
Tristan Pascart
,
René-Marc Flipo
,
Gérard Chalès
,
Laurence Coblentz-Baumann
et al.
Journal articles
hal-03491421v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Recommandations 2020 de la Société française de rhumatologie pour la prise en charge de la goutte : traitement des crises de goutte
Augustin Latourte
,
Tristan Pascart
,
René-Marc Flipo
,
Gérard Chalès
,
Laurence Coblentz-Baumann
et al.
Journal articles
hal-03493571v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficacité et tolérance du fébuxostat chez 73 patients goutteux avec une insuffisance rénale chronique stade 4/5 : étude rétrospective de 10 centres
Pierre-Antoine Juge
,
Marie-Elise Truchetet
,
Evangeline Pillebout
,
Sébastien Ottaviani
,
Cécile Vigneau
et al.
Journal articles
hal-01590231v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|